{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bartow",
      "state": "FL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64409",
      "recalling_firm": "OLAAX International",
      "address_1": "6105 Riverlake Blvd",
      "address_2": "N/A",
      "postal_code": "33830-7754",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Nationwide, Puerto Rico and  Venezuela and Bolivia",
      "recall_number": "D-600-2013",
      "product_description": "MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL",
      "product_quantity": "600 boxes",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.",
      "recall_initiation_date": "20130212",
      "center_classification_date": "20130613",
      "termination_date": "20191001",
      "report_date": "20130619",
      "code_info": "All Lots"
    }
  ]
}